Literature DB >> 19339021

Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients.

Akihiro Watanabe1, Takuya Matsushita, Hikaru Doi, Takashi Matsuoka, Hiroshi Shigeto, Noriko Isobe, Yuji Kawano, Shozo Tobimatsu, Jun-ichi Kira.   

Abstract

Neuromyelitis optica (NMO) is claimed to be a distinct disease entity from multiple sclerosis (MS) because of its strong association with NMO-IgG/anti-AQP4 antibody; however, the in vivo role of the antibody remains unknown. Therefore, we aimed to clarify whether the presence of anti-AQP4 antibody is associated with any abnormalities in multimodality-evoked potentials in 111 patients with relapsing-remitting or relapsing-progressive MS, including the opticospinal form of MS, 18 of whom were seropositive for anti-AQP4 antibody. More patients with anti-AQP4 antibody showed a lack of the P100 component on visual-evoked potentials (VEPs) than those without the antibody (11/17, 64.7% vs. 20/84, 23.8%, p=0.003), whereas the frequency of delayed P100 latency was significantly higher in the latter group than in the former (1/17, 5.9% vs. 28/84, 33.3%, p=0.021). The frequencies of non-responses and delayed central sensory conduction times in median and posterior tibial nerve somatosensory-evoked potentials (SEPs) were not significantly different between anti-AQP4 antibody-positive and -negative patients. In terms of upper and lower limb motor-evoked potentials (MEPs), the frequencies of non-responses and delayed central motor conduction times did not differ significantly based on the presence or absence of anti-AQP4 antibody. The frequency of optic nerve lesions on MRI was significantly higher in anti-AQP4 antibody-positive patients than in anti-AQP4 antibody-negative patients (p=0.0137). Multiple logistic analyses revealed that anti-AQP4 antibody positivity (OR=8.406, p=0.02) and unevoked VEP responses (OR=35.432, p<0.001) were significantly related to development of severe visual impairment. Such an association of anti-AQP4 antibody with disability was not found for either severe motor or sensory impairment. These findings suggest a distinctive nature of optic nerve lesions between anti-AQP4 antibody-positive and -negative patients; lesions are supposed to be more necrotic in the former group and more demyelinating in the latter.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339021     DOI: 10.1016/j.jns.2009.02.371

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Visual abnormalities associated with enhanced optic nerve myelination.

Authors:  Minzhong Yu; S Priyadarshini Narayanan; Feng Wang; Emily Morse; Wendy B Macklin; Neal S Peachey
Journal:  Brain Res       Date:  2010-12-21       Impact factor: 3.252

2.  Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.

Authors:  Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Satoshi Yoshimura; Jakub Fichna; Shu Chen; Jadwiga Furmaniak; Bernard Rees Smith; Jun-Ichi Kira
Journal:  Neurochem Res       Date:  2013-03-02       Impact factor: 3.996

3.  In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.

Authors:  Marco Vabanesi; Marco Pisa; Simone Guerrieri; Lucia Moiola; Marta Radaelli; Stefania Medaglini; Vittorio Martinelli; Giancarlo Comi; Letizia Leocani
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

4.  Visual Evoked Potentials in Neuromyelitis Optica Spectrum Disorders.

Authors:  Otto Jesus Hernandez Fustes; Cláudia S K Kay; Paulo José Lorenzoni; Renata D-P Ducci; Lineu C Werneck; Rosana Herminia Scola
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-21

5.  The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience.

Authors:  Mohammad Mahdi Nasehi; Mohammad Ghofrani; Aydin Tabrizi; Fatemeh Abdollah Gorji; Bakhtyar Khosravi
Journal:  Iran J Child Neurol       Date:  2022-07-16

Review 6.  The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.

Authors:  Michalina Jasiak-Zatonska; Alicja Kalinowska-Lyszczarz; Slawomir Michalak; Wojciech Kozubski
Journal:  Int J Mol Sci       Date:  2016-03-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.